A detailed history of Brewin Dolphin Wealth Management LTD transactions in Horizon Therapeutics Public LTD CO stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 4,475 shares of HZNP stock, worth $0. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,475
Previous 4,475 -0.0%
Holding current value
$0
Previous $471,000 24.2%
% of portfolio
0.04%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Nov 14, 2022

BUY
$98.56 - $119.91 $441,056 - $536,597
4,475 New
4,475 $482,000
Q1 2021

Nov 09, 2023

BUY
$71.83 - $95.48 $7,183 - $9,548
100 Added 2.04%
5,000 $460 Million
Q3 2020

Nov 09, 2023

SELL
$55.23 - $79.93 $44,184 - $63,944
-800 Reduced 14.04%
4,900 $381 Million
Q2 2020

Nov 09, 2023

BUY
$30.2 - $56.98 $36,995 - $69,800
1,225 Added 27.37%
5,700 $317 Million
Q2 2019

Nov 09, 2023

BUY
$22.81 - $28.48 $27,942 - $34,888
1,225 Added 27.37%
5,700 $137 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.